V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160012454 | 160005981 | 1.65 | 60.9 | Palliative (P) | 2020-06-02 | 2020-06-04 | Doxorubicin + Ifosfamide | 02 | N | TRIAL | 101342933 |
| 160012455 | 160005982 | 0 | 9.3 | Palliative (P) | 2017-01-12 | 2017-01-26 | Cisplatin + Pemetrexed | N | Y | CISPLATIN + PEMETREXED | 100067373 |
| 160012456 | 160005983 | 1.75 | 93.9 | null | 2019-09-16 | 2019-09-16 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101538361 |
| 160012458 | 160005984 | 1.82 | 100 | Neo-adjuvant (N) | 2016-09-01 | 2016-09-09 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101134666 |
| 160012459 | 160005985 | 1.89 | 99.3 | Neo-adjuvant (N) | 2016-08-24 | 2016-08-24 | NB HRNBL-1 COJEC Ind COURSE A | 02 | N | DACTINOMYCIN + DOXORUBICIN + IFOSFAMIDE + VINCRISTINE | 100981203 |
| 160012460 | 160005986 | 1.62 | 77 | Palliative (P) | 2019-08-15 | 2019-09-01 | CYCLOPHOSPHAMIDE + DACTINOMYCIN + VINCRISTINE | 02 | N | DOXORUBICIN + OLARATUMAB | 101206560 |
| 160012463 | 160005987 | 1.79 | 81 | Curative (C) | 2018-01-07 | 2018-01-20 | Liposomal Doxorubicin (Caelyx) | 02 | N | ABIRATERONE | 101747537 |
| 160012465 | 160005988 | 1.6 | 88.7 | 03 | 2017-10-10 | 2017-10-27 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 100444237 |
| 160012469 | 160005989 | 1.69 | 76.8 | Palliative (P) | 2018-06-21 | 2018-06-21 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101828979 |
| 160012470 | 160005990 | 1.51 | 83 | Palliative (P) | 2016-11-30 | 2016-12-19 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100141184 |
| 160012471 | 160005991 | 1.77 | 73.6 | Palliative (P) | 2018-04-21 | 2018-04-21 | FLUOROURACIL + OXALIPLATIN | 02 | N | CISPLATIN + CYTARABINE + ETOPOSIDE | 100906104 |
| 160012472 | 160005992 | 1.65 | null | Palliative (P) | 2016-07-23 | 2016-08-01 | Cisplatin + Pemetrexed | 2 | null | CISPLATIN + PEMETREXED | 101179114 |
| 160012474 | 160005993 | 1.46 | 61.4 | Neo-adjuvant (N) | 2018-07-15 | 2018-07-15 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101196134 |
| 160012477 | 160005994 | 1.85 | 65.1 | Palliative (P) | 2016-06-12 | 2016-06-30 | VIDE | 02 | N | IDELALISIB | 101276468 |
| 160012478 | 160005995 | 0 | 7.7 | Palliative (P) | 2018-05-12 | 2018-06-03 | VIDE | 02 | N | CISPLATIN + DOXORUBICIN | 100232645 |
| 160012481 | 160005996 | 1.75 | 80.4 | Palliative (P) | 2018-01-01 | 2018-01-02 | STS Rhabdomyosarco RMS 2005 IVADoVV | 02 | N | DOXORUBICIN | 101448757 |
| 160012482 | 160005997 | 1.74 | 62.7 | Palliative (P) | 2018-06-18 | 2018-07-22 | Paclitaxel 7 day | 2 | N | CARBOPLATIN + PACLITAXEL | 100225899 |
| 160012483 | 160005998 | 1.68 | 99.2 | Neo-adjuvant (N) | 2018-06-06 | 2018-06-13 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 101868303 |
| 160012487 | 160005999 | 1.56 | 62.1 | Palliative (P) | 2018-03-16 | 2018-04-11 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101103367 |
| 160012488 | 160006000 | 1.63 | 102.9 | Palliative (P) | 2016-03-07 | 2016-03-17 | null | 02 | N | DOXORUBICIN + IFOSFAMIDE | 101056923 |
| 160012492 | 160006001 | 1.8 | 55 | Palliative (P) | 2020-02-06 | 2020-02-22 | DOXORUBICIN + IFOSFAMIDE | 02 | N | EW EUROEWING 2012 ARM B VDC | 100954195 |
| 160012493 | 160006002 | 1.8 | 77 | Palliative (P) | 2018-09-27 | 2018-09-30 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101853249 |
| 160012495 | 160006003 | 1.63 | 93 | Curative (C) | 2019-03-15 | 2019-03-17 | Liposomal Doxorubicin 40mg/m2 | 2 | N | STS RHABDOMYOSARCOMA RMS 2005 IVAVV | 100946188 |
| 160012496 | 160006004 | 1.64 | 69.8 | Palliative (P) | 2019-03-05 | 2019-03-11 | Cisplatin + Pemetrexed | 01 | N | CISPLATIN + PEMETREXED | 100503222 |
| 160012498 | 160006005 | 1.67 | 82 | Neo-adjuvant (N) | 2016-06-30 | 2016-07-14 | ICON8B TRIAL | 02 | N | IPILIMUMAB + NIVOLUMAB | 101189852 |
| 160012500 | 160006006 | 1.8 | 74 | Neo-adjuvant (N) | 2020-02-12 | 2020-02-19 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 101099847 |
| 160012501 | 160006007 | 1.73 | 47.6 | null | 2016-07-01 | 2016-07-14 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 100360893 |
| 160012502 | 160006008 | 1.78 | 64 | Palliative (P) | 2019-02-08 | 2019-02-17 | Trial Unspecified | 02 | N | LIPOSOMAL DOXORUBICIN | 101012812 |
| 160012509 | 160006009 | 0 | 90.5 | Palliative (P) | 2016-05-10 | 2016-05-14 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100136703 |
| 160012510 | 160006010 | 1.73 | 67 | Palliative (P) | 2018-02-07 | 2018-02-21 | DOXORUBICIN | 02 | null | EW EUROEWING 2012 ARM B VDC | 101711048 |
| 160012511 | 160006011 | 1.76 | 56.6 | null | 2018-05-19 | 2018-05-25 | Cisplatin + Docetaxel +Fluorouracil | 02 | null | VINORELBINE | 101870072 |
| 160012513 | 160006012 | 1.57 | 77 | Curative (C) | 2018-01-18 | 2018-02-01 | DOXORUBICIN | null | N | TRIAL UNSPECIFIED | 101339763 |
| 160012515 | 160006013 | 1.78 | 70 | Neo-adjuvant (N) | 2019-03-08 | 2019-03-09 | Liposomal Doxorubicin (Caelyx) | null | null | CISPLATIN + GEMCITABINE | 101705362 |
| 160012518 | 160006014 | null | null | null | 2017-10-12 | 2017-10-26 | Doxorubicin 75mg/m2 | 02 | null | DOXORUBICIN | 100889455 |
| 160012522 | 160006015 | null | null | null | 2018-11-24 | 2018-12-03 | Cisplatin + Pemetrexed | N | null | CISPLATIN + PEMETREXED | 101820012 |
| 160012523 | 160006016 | 1.81 | 75 | Palliative (P) | 2016-06-11 | 2016-06-22 | Trial Unspecified | 02 | N | DOXORUBICIN | 100982260 |
| 160012524 | 160006017 | 1.66 | 20 | Curative (C) | 2016-04-17 | 2016-04-20 | CYCLO + DOXORUBICIN + VINCRISTINE | 02 | N | CARBOPLATIN + GEMCITABINE | 101816465 |
| 160012526 | 160006018 | 1.78 | 86.2 | Palliative (P) | 2017-08-23 | 2017-09-25 | Trial Unspecified | null | null | TRIAL UNSPECIFIED | 101403681 |
| 160012528 | 160006019 | 1.66 | 93 | Adjuvant (A) | 2019-02-03 | 2019-02-03 | Cisplatin + Pemetrexed | null | null | CISPLATIN + PEMETREXED | 100707831 |
| 160012531 | 160006021 | 1.74 | 79.5 | Palliative (P) | 2017-07-22 | 2017-07-31 | EW EuroEwing 2012 Arm B VDC | 02 | N | ATEZOLIZUMAB | 101265360 |
| 160012532 | 160006022 | 1.64 | 68 | Palliative (P) | 2018-08-30 | 2018-09-06 | Cisplatin + Pemetrexed | null | N | CISPLATIN + PEMETREXED | 100686683 |
| 160012534 | 160006023 | 1.79 | 77.5 | Palliative (P) | 2018-04-18 | 2018-05-11 | OST Euramos 1 Closed Trial - AP | 02 | null | CARBOPLATIN + VINORELBINE | 100706803 |
| 160012535 | 160006024 | 0.6 | 44 | Curative (C) | 2017-01-01 | 2017-01-17 | CARBOPLATIN + PACLITAXEL | 02 | N | CARBOPLATIN + PACLITAXEL | 100421950 |
| 160012536 | 160006025 | 1.74 | 113.9 | Palliative (P) | 2019-01-26 | 2019-02-07 | LANREOTIDE | 02 | N | DOXORUBICIN | 101073625 |
| 160012538 | 160006027 | 1.68 | 85.25 | 03 | 2017-11-21 | 2017-11-24 | Doxorubicin + Ifosfamide | 02 | N | OSIMERTINIB | 100588916 |
| 160012539 | 160006028 | 1.72 | 48.5 | null | 2019-09-11 | 2019-10-03 | Cisplatin + Pemetrexed | 2 | null | CISPLATIN + PEMETREXED | 101720638 |
| 160012540 | 160006029 | 1.58 | 52.7 | Palliative (P) | 2016-09-30 | 2016-10-17 | IPM | 01 | N | OCTREOTIDE | 101768507 |
| 160012543 | 160006031 | 1.53 | 93.3 | Curative (C) | 2018-09-01 | 2018-09-01 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 101045850 |
| 160012544 | 160006032 | 1.69 | 18.2 | null | 2018-10-12 | 2018-10-12 | null | 02 | N | DOXORUBICIN | 100877271 |
| 160012547 | 160006033 | null | null | Neo-adjuvant (N) | 2018-08-03 | 2018-08-03 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100327451 |